Key result
Ethanol withdrawal in chronic alcoholics increased ADP-stimulated platelet TXB2 formation to markedly higher levels than in nonalcoholic controls at 9-14 days (p<0.01).
Why the study?
Does ethanol withdrawal affect platelet thromboxane formation capacity in chronic alcoholics compared to healthy controls?
Population
14 chronic alcoholics (7 with biopsy-verified alcoholic fatty liver) and nonalcoholic healthy controls
Comparison
Ethanol withdrawal vs Nonalcoholic healthy controls
Design
Cohort
Follow-up
9-14 days
Authors
Loading...
Rebound TXB2 rise may signal transient prothrombotic risk in withdrawing alcoholics; hypothesis-generating and requires prospective validation.
Observational (n=14)
Does ethanol withdrawal affect platelet thromboxane formation capacity in chronic alcoholics compared to healthy controls?
p-value: p=<0.01
Ethanol withdrawal in chronic alcoholics leads to a rebound increase in ADP-stimulated platelet thromboxane formation, suggesting a potential transient pro-thrombotic state.
Hillbom et al. (2009) conducted an observational in Chronic alcoholism (n=14). Ethanol withdrawal vs. Nonalcoholic healthy controls was evaluated on Platelet thromboxane B2 (TXB2) formation (p=<0.01). Ethanol withdrawal in chronic alcoholics increased ADP-stimulated platelet TXB2 formation to markedly higher levels than in nonalcoholic controls at 9-14 days (p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: